Skip to main content

Table 5 Association analysis of apo B with hyperuricaemia (left) and serum urate (right)

From: The relationship of apolipoprotein B and very low density lipoprotein triglyceride with hyperuricemia and gout

  NU vs. HU and gout   Vs. urate in NU and HU groups
Unadjusted OR [95% CI] P Adjusted OR [95% CI] P Unadjusted β[95% CI] P Adjusted β[95% CI] P
Total apo B ( μmol/L)         
Europeans 0.58 [0.24-1.39] 0.22 0.46 [0.15-1.46] 0.19 -0.026 [-0.071-0.019] 0.26 -0.014 [-0.048-0.020] 0.41
Polynesians 0.27 [0.10-0.75] 0.012 0.20 [0.04-0.96] 0.044 -0.038 [-0.071--0.004] 0.031 -0.017 [-0.057-0.023] 0.40
Combined 0.41 [0.22-0.77] 0.005 0.47 [0.21-1.04] 0.062 -0.034 [-0.061--0.007] 0.013 -0.020 [-0.045-0.005] 0.12
VLDL apo B (0.1μmol/L)         
Europeans 8.13 [2.04-32.42] 0.003 4.04 [0.82-19.83] 0.086 0.046 [0.011-0.081] 0.011 0.001 [-0.002-0.004] 0.48
Polynesians 2.32 [0.89-6.05] 0.084 1.81 [0.51-6.47] 0.36 0.045 [-0.007-0.098] 0.089 -0.002 [-0.004-0.0004] 0.099
Combined 3.80 [1.74-8.33] 0.001 2.50 [1.00-6.26] 0.050 0.046 [0.017-0.075] 0.002 -0.001 [-0.003-0.0005] 0.18
  1. Adjusted for age, BMI, type 2 diabetes, SSB intake (drinks/day), alcohol intake (drinks/week), eGFR, hypertension and prescription of lipid-lowering medication. The Polynesian data are also adjusted by number of self-reported Polynesian grandparents. The combined analysis was additionally adjusted by ancestral group. NU: normouricaemia; HU: hyperuricaemia; OR: odds ratio; CI: confidence interval; apo B: apolipoprotein B; VLDL: very low-density lipoprotein; BMI, body mass index; SSB: sugar-sweetened beverage; eGRF: estimated glomerular filtration rate.